Holos Integrated Wealth’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$94.3K Hold
6,500
0.04% 123
2026
Q1
$52.4K Hold
6,500
0.03% 154
2025
Q4
$76.4K Hold
6,500
0.04% 107
2025
Q3
$59.1K Sell
6,500
-20,000
-75% -$140K 0.03% 111
2025
Q2
$154K Hold
26,500
0.09% 72
2025
Q1
$251K Hold
26,500
0.16% 54
2024
Q4
$437K Buy
+26,500
New +$412K 0.3% 39

Other funds holding NEO

Holos Integrated Wealth's NEO Position: Q2 2026 in Review

Holos Integrated Wealth held its NeoGenomics (NEO) position steady in Q2 2026 at 6,500 shares worth $94.3K. The position accounts for 0.04% of the portfolio, ranked #123.

Holos Integrated Wealth first reported a position in NEO in Q4 2024 and has held it in 7 quarters since. The position peaked at $437K in Q4 2024. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Holos Integrated Wealth held 6,500 shares of NeoGenomics worth $94.3K as of Q2 2026.
  • Holos Integrated Wealth left its NeoGenomics share count unchanged in Q2 2026.
  • NeoGenomics made up 0.04% of Holos Integrated Wealth's portfolio in Q2 2026, its #123 holding.
  • Holos Integrated Wealth first reported a position in NeoGenomics in Q4 2024 and has held it in 7 quarters since.
  • Holos Integrated Wealth's NeoGenomics position peaked at $437K in Q4 2024.
  • 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Holos Integrated Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.